Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-05-10-Speech-4-315-625"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-05-10"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20120510.69.4-315-625"2
lpv:hasSubsequent	lp_eu:2012-05-10-Speech-4-315-7502
lpv:speaker	lp:José Manuel Fernandes2
lpv:spokenAs	substitute; Delegation to the ACP-EU Joint Parliamentary Assembly (2010-03-05--2014-06-30)3 substitute; Delegation for relations with India (2009-09-16--2014-06-30)3 member; Delegation for relations with the People's Republic of China (2009-09-16--2014-06-30)3 member; EPP (2009-07-14--2014-06-30)3 substitute; ENVI (2012-01-19--2014-06-30)3 unknown; Partido Social Democrata (2009-07-14--2014-06-30)3 member; BUDG (2012-01-19--2014-06-30)3
lpv:translated text	"This report, by Ms Macovei, concerns discharge in respect of the implementation of the budget of the European Medicines Agency (EMA) for the financial year 2010. The EMA, which was created in 1993 but only became operational in 1995, is aimed at protecting and promoting public and animal health by evaluating and supervising medicines for human or veterinary use. No medicine can be marketed without this agency’s assent. The Court of Auditors’ report, despite making some observations on carryovers, IT contracts and the payment system, considered that the accounts of the EMA for the financial year 2010 ‘are reliable, legal and regular’. Thus, in view of the opinion of the Committee on the Environment, Public Health and Food Safety, I am voting against this report, as I believe that, as with the other agencies, the Director of the EMA should also be granted discharge in respect of the implementation of the agency’s budget for the financial year 2010."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph